ALPANSEAlpa Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 27 Jun · 14:52 IST

Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Alpa Laboratories has informed the stock exchanges that its trading window will be closed starting 1st July 2025, in line with SEBI's insider trading regulations. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter ending 30th June 2025 (Q1 FY26). During this period, designated insiders including directors, promoters, and certain employees are prohibited from trading in the company's shares. This is a routine compliance filing made ahead of the upcoming quarterly earnings announcement.

Likely market impact

This is a standard regulatory disclosure and does not directly affect retail shareholders. However, it signals that the Q1 FY26 results announcement is likely in the coming weeks, which could influence short-term stock movement once the window reopens.